BIORBYT LTD. Non-Antibody Products — page 3 of 7
Non-Antibody Products
Page 3,686 of 7,959
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| IFNGR1 siRNA (Mouse) | siRNA to inhibit IFNGR1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1847277 | More Info |
| IFNG siRNA (Human) | siRNA to inhibit IFNG expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1865914 | More Info |
| IFNG siRNA (Mouse) | siRNA to inhibit IFNG expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1847278 | More Info |
| IFNG siRNA (Rat) | siRNA to inhibit IFNG expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1833014 | More Info |
| IFNK siRNA (Human) | siRNA to inhibit IFNK expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1857077 | More Info |
| IFNK siRNA (Mouse) | siRNA to inhibit IFNK expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1834306 | More Info |
| IFN lambda 2 Recombinant Protein | IFN lambda 2 Recombinant Protein. Purity >98% by SDS-PAGE gel and HPLC ana… | 0.02 mg, 0.005 mg | orb1230669 | More Info |
| IFN-Lambda-1 Recombinant Protein (Animal Free) | IFN-Lambda-1 Recombinant Protein (Animal Free). Purity ≥ 98% by SDS-PAG… | 5 ug | orb1230367 | More Info |
| IFN lamda 1 Recombinant Protein | IFN lamda 1 Recombinant Protein. Purity >98% by SDS-PAGE gel and HPLC anal… | 0.02 mg, 0.005 mg | orb1230829 | More Info |
| IFN lamda 2 Recombinant Protein | IFN lamda 2 Recombinant Protein. Purity >98% by SDS-PAGE gel and HPLC anal… | 0.02 mg, 0.005 mg | orb1230830 | More Info |
| IFNLR1 siRNA (Human) | siRNA to inhibit IFNLR1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1852263 | More Info |
| IFNLR1 siRNA (Mouse) | siRNA to inhibit IFNLR1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1835660 | More Info |
| IFNL1 siRNA (Human) | siRNA to inhibit IFNL1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1851413 | More Info |
| IFNL2 siRNA (Human) | siRNA to inhibit IFNL2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1851415 | More Info |
| IFNL3 siRNA (Human) | siRNA to inhibit IFNL3 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1851414 | More Info |
| IFNL4 siRNA (Human) | siRNA to inhibit IFNL4 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1849296 | More Info |
| IFNL2 siRNA (Mouse) | siRNA to inhibit IFNL2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1834640 | More Info |
| IFNL3 siRNA (Mouse) | siRNA to inhibit IFNL3 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1834563 | More Info |
| IFN-omega Protein, Human, Recombinant (hFc) | Purity 98.00%. MW: approxiamtely 46.6 kDa | 100 ug | orb1958759 | More Info |
| IFN-omega Protein, Human, Recombinant (His) | Purity 99.10%. MW: approxiamtely 21.6 kDa | 100 ug | orb1956625 | More Info |
| IFN omega 1 Recombinant Protein | IFN omega 1 Recombinant Protein. Purity >95% as determined by reducing SDS… | 0.05 mg | orb1229056 | More Info |
| IFN-omega Recombinant Protein | IFN-omega Recombinant Protein. Purity >98% by SDS-PAGE gel and HPLC analys… | 0.1 mg, 0.02 mg | orb1230596 | More Info |
| IFNW1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb596619 | More Info |
| IFNW1 Human Over-expression Lysate | IFNW1 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1365229 | More Info |
| IFNW1 Human Over-expression Lysate | Transient overexpression lysate of interferon, omega 1 (IFNW1) | 100 ug | orb1344889 | More Info |
| IFNW1 peptide | The peptide is used to block anti-IFN omega antibody reactivity. Purity >… | 5 mg, 1 mg | orb217440 | More Info |
| IFNW1 siRNA (Human) | siRNA to inhibit IFNW1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1865911 | More Info |
| IFN-y Recombinant Protein | IFN-y Recombinant Protein. Purity >98% by SDS-PAGE gel and HPLC analyses. | 0.1 mg | orb1230559 | More Info |
| Ifosfamide | A nitrogen mustard alkylating agent used in the treatment of cancer. Purit… | 200 mg, 100 mg | orb1225156 | More Info |
| Ifosfamide | Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of… | 1 g | orb341974 | More Info |
| Ifosfamide | Purity ≥98%. MW: 261.09 | 1 g, 250 mg, 50 mg, 25 mg | orb609407 | More Info |
| Ifosfamide | Purity 99.86%. MW: 261.09 | 100 mg, 200 mg, 500 mg | orb1309923 | More Info |
| Ifosfamide | n/a | 100 mg, 10 mm, 250 mg, 500 mg, 1000 mg | orb1904251 | More Info |
| Ifoxetine | Purity 98.00%. MW: 221.3 | 5 mg, 50 mg, 100 mg | orb1740570 | More Info |
| Ifoxetine sulfate | Purity 98.00%. MW: 270.34 | 5 mg, 50 mg, 100 mg | orb1700361 | More Info |
| IFRD1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb596620 | More Info |
| IFRD2 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb596621 | More Info |
| IFRD1 Human Over-expression Lysate | IFRD1 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1362787 | More Info |
| IFRD1 Human Over-expression Lysate | Transient overexpression lysate of interferon-related developmental regula… | 100 ug | orb1344589 | More Info |
| IFRD1 Human Over-expression Lysate | Transient overexpression lysate of interferon-related developmental regula… | 100 ug | orb1342446 | More Info |
| IFRD2 Human Over-expression Lysate | IFRD2 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1367513 | More Info |
| IFRD2 Human Over-expression Lysate | Transient overexpression lysate of interferon-related developmental regula… | 100 ug | orb1347174 | More Info |
| IFRD1 siRNA (Human) | siRNA to inhibit IFRD1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1865910 | More Info |
| IFRD2 siRNA (Human) | siRNA to inhibit IFRD2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1862958 | More Info |
| IFRD1 siRNA (Mouse) | siRNA to inhibit IFRD1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1847276 | More Info |
| IFRD1 siRNA (Rat) | siRNA to inhibit IFRD1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1832646 | More Info |
| I-49 free base | I-49 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibit… | 25 mg, 10 mg, 5 mg | orb1219450 | More Info |
| I-49 free base | Purity 99.88%. MW: 482.92 | 5 mg, 10 mg, 25 mg, 1 mg, 50 mg | orb1298667 | More Info |
| I-37 free base( 2359690-13-2(free base)) | I-37 free base is a novel benzylamino substituted pyridopyrimidinone as SO… | 100 mg, 50 mg, 25 mg, 10 mg, 5 mg | orb1219445 | More Info |
| I-37 free base( 2359690-13-2(free base)) | I-37 free base( 2359690-13-2(free base)). Purity 99.75%. MW: 452.9 | 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 mg | orb1298686 | More Info |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Return to Profile